Companies › BNY

BNY 10-K & 10-Q changes, risk factors and insider trading

Bank of New York Mellon Corp (also BNY-PK) · NYSE · State Commercial Banks · CIK 1390777 · All filings on SEC.gov

Everything below is quoted or computed from Bank of New York Mellon Corp's public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

0 / 0risk-factor paragraphs added / removed in latest 10-K
0new risk-factor headings
0Form 4 filings reporting open-market purchases (last 180 days)
7Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparing 10-K filed 2026-02-25 (period ending 2025-12-31) with 10-K filed 2025-02-27 (period ending 2024-12-31).

Risk Factors (10-K Item 1A)

0new paragraphs
0removed paragraphs
0reworded paragraphs
25 → 25words in section

The section in the latest 10-K reads in full:

The information required by this Item is set forth in the Annual Report under “MD&A – Risk Factors,” which portion is incorporated herein by reference.

No wording changes found in this section.

Full comparison: every changed paragraph (0)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Management's Discussion & Analysis (MD&A) (10-K Item 7)

0new paragraphs
0removed paragraphs
1reworded paragraphs
41 → 40words in section

The section in the latest 10-K reads in full:

The information required by this Item is set forth in the MD&A and Notes 5, 11, 13, 18, 21 and 22 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Reworded

Paragraph as it now reads, with added and removed wording marked:

The information required by this Item is set forth in the MD&A and Notes 3,5, 6,11, 12,13, 14,18, 19, 2221 and 2322 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.
see in full comparison
Full comparison: every changed paragraph (1)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

The information required by this Item is set forth in the MD&A and Notes 3,5, 6,11, 12,13, 14,18, 19, 2221 and 2322 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.

What changed in the latest 10-Q

Comparing 10-Q filed 2026-07-31 (period ending 2026-06-30) with 10-Q filed 2026-05-01 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

We could not find a separate Risk Factors item in the latest 10-Q. Some companies leave it out of quarterly reports; see the annual 10-K risk factors and the original filing. Open the filing on SEC.gov.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

Not available: the section could not be located automatically in both filings (non-standard layout or incorporated by reference). See the original filing. Open the filing on SEC.gov.

BNY insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 7 filings (6 insiders, 4 trade dates, 86,931 shares, about $12.6M; 2 of these filings say the sales were made under a Rule 10b5-1 trading plan). Net open-market shares: -86,931 (purchases minus sales); net value about -$12.6M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

Trade dateInsiderTransactionSharesPriceValueOwned afterFiling
2026-10-01Robinson Elizabeth
Director
Grant/award 74$143.92 $10.6K5,510 SEC
2026-10-01O'connor Sandra
Director
Grant/award 191$143.92 $27.5K7,335 SEC
2026-10-01Goldstein Jeffrey A
Director
Grant/award 287$143.92 $41.2K43,220 SEC
2026-10-01Echevarria Joseph
Director
Grant/award 625$143.92 $90.0K67,575 SEC
2026-09-28Minaya Jose
Senior Executive VP
Open-market sale
10b5-1 plan
22$149.87 $3.3K176,824 SEC
2026-09-28Minaya Jose
Senior Executive VP
Open-market sale
10b5-1 plan
1,843$148.34 $273.4K178,501 SEC
2026-09-28Minaya Jose
Senior Executive VP
Open-market sale
10b5-1 plan
1,655$149.27 $247.0K176,846 SEC
2026-08-27Minaya Jose
Senior Executive VP
Open-market sale
10b5-1 plan
2,590$162.45 $420.7K181,274 SEC
2026-08-27Minaya Jose
Senior Executive VP
Open-market sale
10b5-1 plan
930$163.17 $151.7K180,344 SEC
2026-08-05Mccarthy J Kevin
SEVP & General Counsel
Gift 249— —49,989 SEC
2026-07-29Mcdonogh Dermot
Chief Financial Officer
Open-market sale 9,000$153.78 $1.4M22,800 SEC
2026-07-29Mcdonogh Dermot
Chief Financial Officer
Open-market sale 5,297$154.90 $820.5K17,503 SEC
2026-07-29Mcdonogh Dermot
Chief Financial Officer
Gift 31,800— —248,727 SEC
2026-07-29Mcdonogh Dermot
Chief Financial Officer
Open-market sale 7,200$156.68 $1.1M0 SEC
2026-07-29Mcdonogh Dermot
Chief Financial Officer
Open-market sale 10,303$155.76 $1.6M7,200 SEC
2026-07-29Mcdonogh Dermot
Chief Financial Officer
Gift 31,800— —31,800 SEC
2026-07-16Vince Robin A.
Director, Chairman & CEO
Other 24,833$161.08 $4.0M625,794 SEC
2026-07-16Vince Robin A.
Director, Chairman & CEO
Other 24,833$161.08 $4.0M24,833 SEC
2026-07-01O'connor Sandra
Director
Grant/award 188$146.02 $27.5K7,116 SEC
2026-07-01Robinson Elizabeth
Director
Grant/award 73$146.02 $10.6K5,415 SEC
2026-07-01Goldstein Jeffrey A
Director
Grant/award 282$146.02 $41.3K42,763 SEC
2026-07-01Echevarria Joseph
Director
Grant/award 616$146.02 $90.0K66,683 SEC
2026-04-17Perez Alejandro
Sr. Executive Vice President
Open-market sale 12,504$137.01 $1.7M62,613 SEC
2026-04-17Perez Alejandro
Sr. Executive Vice President
Gift 1,000— —75,117 SEC
2026-04-17Kurimsky Kurtis R.
Corporate Controller
Open-market sale 5,290$136.02 $719.5K17,259 SEC
2026-04-17Mccarthy J Kevin
SEVP & General Counsel
Open-market sale 30,000$136.50 $4.1M50,238 SEC
2026-04-17Hobbs Shannon Marie
Senior Executive VP
Open-market sale 297$137.05 $40.7K15,206 SEC

Well-known investors holding BNY (13F)

InvestorQuarterSharesReported value% of their 13FChange vs prior quarter
Dodge & Cox COM2026-06-3016,608,370$2.4B1.26%Reduced 29%
Davis Selected Advisers (Chris Davis) Common Stock2026-06-30366,448$53.0M0.23%Reduced 30%
Tweedy, Browne COM2026-06-30102,246$14.8M1.12%Reduced 6%
Yacktman Asset Management COM2026-06-3064,400$9.3M0.12%Reduced 82%

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when BNY files, watchlists and downloadable comparisons.